Table 1 Patients characteristics
PI Monotherapy (N = 25) | cART (N = 56) | P1 | |||
|---|---|---|---|---|---|
N | % | N | % | ||
Female sex | 1 | 4.0 | 15 | 26.8 | 0.017 |
Detectable HIV-RNA2 | 2 | 8.0 | 3 | 5.4 | 0.648 |
hsCRP >3 mg/l | 5 | 20.8 | 11 | 20.0 | 0.577 |
SAA >6.4 mg/l | 9 | 37.5 | 12 | 21.82 | 0.172 |
IL6 > 3 pg/ml | 1 | 4.8 | 1 | 1.9 | 0.490 |
PI exposure | 25 | 100.0 | 32 | 57.0 | |
ATV/RTV | 3 | 12.0 | 16 | 28.6 | |
DRV/RTV | 20 | 80.0 | 9 | 16.1 | |
LPV/RTV | 2 | 8.0 | 4 | 7.1 | |
Other PI | 0 | 0.0 | 3 | 5.4 | |
NNRTI exposure | 23 | 41.1 | |||
EFV | 11 | 19.6 | |||
NVP | 12 | 21.4 | |||
NRTI exposure | 56 | 100.0 | |||
ABC | 54 | 96.4 | |||
TDF | 5 | 8.9 | |||